GlassScriptPhysician profile
Brian J Shore
NPI 1811948755
$448.82
in general payments reported to CMS, 2019-2025
9 companies · $213 in 2025
The $213 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.56 · 2021: $22.63 · 2022: $95.17 · 2023: $25.15 · 2024: $20.09 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $258.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $148.41 | 2021-2025 | In.Pact Admiral, Hawkone, Abre |
| Angiodynamics, INC. | $117.57 | 2019-2025 | Smart Port Ct |
| Mozarc Medical US LLC | $42.78 | 2024-2025 | Palindrome, Chameleon |
| Cook Medical LLC | $33.40 | 2022 | |
| Bard Peripheral Vascular, INC. | $30.17 | 2025 | Bard Marquee |
| Cardiovascular Systems INC. | $26.07 | 2019 | |
| W. L. Gore & Associates, INC. | $21.50 | 2025 | Gore Excluder Iliac Branch Endoprosthesis |
| Baxter Healthcare | $17.97 | 2019 | |
| Medtronic Vascular, INC. | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Shore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.